Production (Stage)
BiomX Inc.
PHGE
$0.50
-$0.017-3.29%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 55.89% | 54.77% | 34.13% | 16.07% | 1.30% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 47.96% | 40.25% | 26.03% | 21.27% | -1.78% |
| Operating Income | -47.96% | -40.25% | -26.03% | -21.27% | 1.78% |
| Income Before Tax | 78.31% | 32.25% | 67.20% | -3.38% | -40.33% |
| Income Tax Expenses | -59.09% | -43.48% | -81.97% | -68.85% | -64.52% |
| Earnings from Continuing Operations | 78.30% | 32.26% | 67.23% | -3.20% | -40.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 78.30% | 32.26% | 67.23% | -3.20% | -40.08% |
| EBIT | -47.96% | -40.25% | -26.03% | -21.27% | 1.78% |
| EBITDA | -45.86% | -37.88% | -26.24% | -23.91% | -1.69% |
| EPS Basic | 99.15% | 53.92% | 59.77% | 43.30% | 28.53% |
| Normalized Basic EPS | 103.31% | 60.79% | 58.53% | 37.78% | 29.78% |
| EPS Diluted | 56.09% | 4.53% | 19.78% | 8.48% | 28.51% |
| Normalized Diluted EPS | 101.24% | 58.47% | 56.58% | 36.08% | 29.78% |
| Average Basic Shares Outstanding | 176.19% | 134.52% | 106.06% | 78.30% | 93.10% |
| Average Diluted Shares Outstanding | 209.44% | 172.67% | 150.94% | 132.78% | 93.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |